Summit Therapeutics Inc. · NASDAQ:SMMT
Duggan Robert W bought 100,000 Summit Therapeutics Inc. shares (Form 4)
Traded Jun 4, 2026 · Filed Jun 4, 2026
On Jun 4, 2026, Duggan Robert W (Director, Co-Chief Executive Officer, 10% owner) bought 100,000 Summit Therapeutics Inc. shares at US$14.60 for US$1.46M, leaving 25,824,474 shares. Filed Jun 4, 2026 (Form 4).
- Bought
- 100,000 shares
- Price
- US$14.60
- Value
- US$1.46M
- Holding after
- 25,824,474 shares (held indirectly)
- Trading plan
- No
- Role
- Director, Co-Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Buy | 100,000 | US$14.60 | 25,824,474 | Indirect |